How should immunodeficiency be evaluated and managed in pediatric patients?

Evaluation and Management of Immunodeficiency in Pediatric Patients

Suspect primary immunodeficiency in children with recurrent bacterial infections of the respiratory tract, failure to thrive with chronic diarrhea, opportunistic infections, or severe infections requiring IV antibiotics, and immediately initiate a stepwise diagnostic approach starting with complete blood count with differential, serum immunoglobulin levels, and lymphocyte subset enumeration. 1

Recognition and Clinical Presentations

Key Warning Signs by Age Group

• Pediatric patients most commonly present with:

  • Recurrent pneumonia 2
  • Failure to thrive 1
  • Need for IV antibiotics 2
  • Serious bacterial infections 2
  • Recurrent otitis media 2
  • Chronic diarrhea 1

• Critical presentations requiring urgent evaluation:

  • SCID: Failure to thrive, chronic diarrhea, severe/disseminated infections, opportunistic infections, rash, or abnormal newborn screen 1
  • DiGeorge syndrome: Hypocalcemic seizures, cardiac disease, abnormal facies, abnormal newborn screen 1
  • Wiskott-Aldrich syndrome: Thrombocytopenia with bleeding, eczema, recurrent infections with encapsulated organisms 1

Important Caveats

• Traditional warning signs show poor diagnostic performance, with sensitivity of only 64% in pediatric populations and <45% in adults 2
• Family history of primary immunodeficiency is the strongest predictor of disease 3
• Autoimmunity occurs more frequently in pediatric immunodeficiency patients and should raise suspicion 2

Diagnostic Approach

Initial Screening Tests (Perform Immediately)

• Complete blood count with differential to identify:

  • Lymphocytopenia (suggests T-cell disorder) 1, 3
  • Neutropenia (suggests phagocytic disorder) 3
  • Thrombocytopenia (consider Wiskott-Aldrich syndrome) 1

• Serum immunoglobulin levels (IgG, IgA, IgM, IgE):

  • Abnormal levels suggest B-cell disorder 1, 3
  • Panhypogammaglobulinemia suggests SCID 1

• Lymphocyte subset enumeration (CD3+, CD4+, CD8+, CD19+, NK cells):

  • Low CD3+ T cells with normal B and NK cells (T-B+NK+ phenotype) suggests athymia 1
  • Absence of B cells suggests agammaglobulinemia 1

Advanced Testing (When Screening Abnormal)

• Specific antibody responses to protein antigens (tetanus, diphtheria) and polysaccharide antigens (pneumococcal) 1
• T-cell proliferation assays with mitogens and antigens 1
• NK cell cytotoxicity testing 1
• Molecular/genetic testing for definitive diagnosis 1

Specialized Testing by Category

• Phagocytic defects: DHR reduction or nitroblue tetrazolium test, flow cytometry for adhesion molecules 1
• Complement deficiency: CH50 and AH50 assays 1
• Genetic confirmation: Microarray, targeted gene sequencing, or whole-exome sequencing 1

Management by Category

Severe Combined Immunodeficiency (SCID) - URGENT

SCID is a medical emergency requiring immediate intervention because these infants can succumb to severe infection at any time. 1

• Immediate supportive measures:

  • Antimicrobial prophylaxis and treatment 1
  • IgG replacement therapy 1
  • Irradiated, CMV-negative blood products only 1
  • Strict isolation precautions 1
  • NO live vaccines 1
  • Withhold breastfeeding from CMV-seropositive mothers 1

• Definitive treatment:

  • Hematopoietic stem cell transplantation (HSCT) as quickly as possible 1
  • Outcomes are greatly improved by earliest possible intervention 1

Congenital Athymia

• Allogeneic thymus transplantation is the definitive treatment 1
• T-cell replete fully matched allogeneic HCT only in certain specific circumstances 1
• Supportive care identical to SCID management 1

Combined Immunodeficiency Syndromes

• Supportive therapy: Antimicrobials and polyclonal human IgG 1
• HSCT has been successfully applied in Wiskott-Aldrich syndrome, DiGeorge syndrome, ataxia-telangiectasia, and hyper-IgE syndromes 1

Humoral (Antibody) Deficiencies

• Agammaglobulinemia or common variable immunodeficiency:

  • IgG replacement therapy (IV or subcutaneous) 1
  • Antibiotic prophylaxis 1

• Milder antibody deficiencies (selective IgA deficiency, IgG subclass deficiency, specific antibody deficiency):

  • Antibiotic prophylaxis as primary management 1
  • IgG therapy can be applied in selected cases 1

Phagocytic Cell Defects

• Chronic granulomatous disease: Antimicrobial prophylaxis, aggressive treatment of infections 1
• Severe neutropenia: May require HSCT 1

Immune Dysregulation Disorders

• Hemophagocytic syndromes: Aggressive chemotherapy followed by HSCT to prevent immediate fatality 1
• Autoimmune lymphoproliferative syndromes: Require HSCT 1

Critical Management Principles

Consultation Requirements

Where uncertainty regarding evaluation or management occurs, consultation with physicians experienced with immunodeficiencies is essential. 1

Molecular Diagnosis Priority

Pursue molecular-level diagnosis to: 1

• Establish unequivocal diagnosis
• Permit accurate genetic counseling
• Allow planning of future pregnancies
• Better define genotype/phenotype associations
• Identify candidates for gene-specific therapies

Monitoring and Surveillance

• Viral PCR monitoring (CMV, EBV, adenovirus, HHV6) 1
• Monitor for immune reconstitution post-transplant 1
• Regular assessment for complications and infections 1

Common Pitfalls to Avoid

• Do not rely solely on warning signs—they have poor sensitivity and specificity 2, 4
• Do not dismiss immunodeficiency in patients with atopy—these conditions can coexist 4
• Do not delay referral while awaiting complete workup—early specialist consultation improves outcomes 1, 3
• Do not administer live vaccines to suspected immunodeficient patients 1
• Do not use non-irradiated or CMV-positive blood products in suspected SCID 1